ADENTRA (TSE:ADEN – Get Free Report) had its price objective reduced by investment analysts at Acumen Capital from C$56.00 to C$54.00 in a research report issued on Friday,BayStreet.CA reports.
Other equities research analysts have also issued reports about the stock. CIBC lifted their price target on shares of ADENTRA from C$52.00 to C$53.00 and gave the stock an “outperform” rating in a research note on Tuesday, August 13th. Cormark boosted their target price on ADENTRA from C$51.50 to C$56.50 in a report on Tuesday, July 30th. Scotiabank raised their price target on ADENTRA from C$51.00 to C$52.50 and gave the stock an “outperform” rating in a research note on Tuesday, July 30th. Stifel Nicolaus cut their price target on ADENTRA from C$53.00 to C$50.00 and set a “buy” rating on the stock in a research report on Thursday, October 17th. Finally, National Bankshares increased their price objective on ADENTRA from C$57.00 to C$60.00 and gave the company an “outperform” rating in a report on Monday, October 7th. Five investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and a consensus target price of $54.33.
Read Our Latest Stock Report on ADEN
ADENTRA Trading Down 4.2 %
Insider Activity at ADENTRA
In other ADENTRA news, Senior Officer Daniel Brian Figgins sold 1,100 shares of the business’s stock in a transaction on Wednesday, September 11th. The stock was sold at an average price of $39.06, for a total transaction of $42,965.12. Company insiders own 10.73% of the company’s stock.
About ADENTRA
ADENTRA Inc engages in the wholesale distribution of architectural building products to the residential, repair and remodel, and commercial construction markets in Canada and the United States. It offers doors, decorative surfaces, moldings, stair parts, hardwood lumber, hardwood plywood, composite panels, and other building products to industrial manufacturers, home builder distribution yards, and home centers.
Featured Articles
- Five stocks we like better than ADENTRA
- Dividend Payout Ratio Calculator
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
- How to Invest in Biotech Stocks
- Freeport-McMoRan, Copper Demand Short-Term Pain, Long-Term Gain
- ETF Screener: Uses and Step-by-Step Guide
- Time to Load Up on Home Builders?
Receive News & Ratings for ADENTRA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ADENTRA and related companies with MarketBeat.com's FREE daily email newsletter.